Search Results for:

A great tweet from Brandon Bergman: There are multiple targets for people with SUD. One – survival. Two – stabilization (job, housing, health). Three – flourishing (living to one's "potential" given all these resources). Field is having 3 conversations at … Continue reading →

This makes zero sense in an opioid crisis. Who wants this? Are doctors and patients saying that the array opioid medications is incomplete? What’s driving this? Public health? Ideology? Market forces? Why are only 4 legislators speaking up? You fill … Continue reading →

I was perusing past year’s articles in Alcoholism Treatment Quarterly and came across these two: Achieving a 15% Relapse Rate: A Review of Collegiate Recovery and Physician Health Programs A Perspective from the Field: The Disconnect between Abstinence-Based Programs and … Continue reading →

From Addiction: . . . whether it is truly an accurate model of human addictive behaviour is more questionable. It is certainly true that numerous studies since Rat Park have shown the importance of environment in influencing human drug use, … Continue reading →

A friend shared this obituary with me today. I don’t know anything about Maddie beyond what’s shared in her obituary, but it’s has to be the most beautifully written obituary I’ve ever seen. Addiction afflicts beautiful, good people and it … Continue reading →

Framing the national drug problem around opioids misses the bigger target. The future of the national drug problem is more drugs used by more drug users – not simply prescription misuse or even opioids but instead globally produced illegal synthetic … Continue reading →

“Vancouver is a city with a lot of harm-reduction tools in its tool box and, still, we’ve barely slowed the wave of overdoses,” Mr. Robertson said. Mr. Robertson is Vancouver’s outgoing mayor. He reflected on his experience managing the city through … Continue reading →

No matter how cynical you become, it’s never enough to keep up. —Lily Tomlin From the Financial Times: A billionaire pharmaceuticals executive who has been blamed for spurring the US opioid crisis stands to profit from the epidemic after he … Continue reading →

UPDATE: looks like this study has been retracted. I’ll post more, when I know more about why. UPDATE 2: German Lopez has an update here. A new meta-analysis of research on supervised injection sites delivers some disappointing conclusions for advocates: … Continue reading →

So, the other night I posted about cash-only buprenorphine practices. The next morning I find this in my mail. Consulting services to help establish turn-key buprenorphine clinics with cash revenue models that use toxicology services to generate revenue and provide … Continue reading →